In the rapidly evolving area of cancer therapeutics, understanding the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is very important for establishing successful treatment plans. Probably the most promising approaches is the use of in vitro bystander outcome assays, which Engage in a pivotal part in maximizing therapeutic efficacy. These… Read More